Arthur M. Brown
Career history of Arthur M. Brown
Former positions of Arthur M. Brown
| Companies | Position | Start | End |
|---|---|---|---|
Laguna Pharmaceuticals, Inc.
 Laguna Pharmaceuticals, Inc. BiotechnologyHealth Technology Laguna Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. Its lead product, Vanoxerine is a therapeutic candidate being developed for treatment of atrial fibrillation and atrial flutter. The firm’s product is a potential pharmaceutical option to rapidly terminate atrial fibrillation in both hospital and home settings. The company was founded in 2006 by Arthur M. Brown and Howard C. Dittrich and is headquartered in Cleveland, OH. | Chief Executive Officer | 06/08/2010 | - |
| Founder | 06/08/2010 | - | |
ChanTest Corp.
 ChanTest Corp. Miscellaneous Commercial ServicesCommercial Services ChanTest Corp. provided testing and discovery services to pharmaceutical and biotech companies. Its services included safety, discovery, cell biology and transporters. The company was founded by Arthur M. Brown in 1998 and was headquartered in Cleveland, OH. | Chief Executive Officer | - | - |
| Founder | 07/12/2009 | - | |
| President | 01/01/1998 | - |
Statistics
International
| United States | 3 |
Operational
| Chief Executive Officer | 2 |
| Founder | 2 |
| President | 1 |
Sectoral
| Commercial Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
ChanTest Corp.
ChanTest Corp. Miscellaneous Commercial ServicesCommercial Services ChanTest Corp. provided testing and discovery services to pharmaceutical and biotech companies. Its services included safety, discovery, cell biology and transporters. The company was founded by Arthur M. Brown in 1998 and was headquartered in Cleveland, OH. | Commercial Services |
Laguna Pharmaceuticals, Inc.
Laguna Pharmaceuticals, Inc. BiotechnologyHealth Technology Laguna Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. Its lead product, Vanoxerine is a therapeutic candidate being developed for treatment of atrial fibrillation and atrial flutter. The firm’s product is a potential pharmaceutical option to rapidly terminate atrial fibrillation in both hospital and home settings. The company was founded in 2006 by Arthur M. Brown and Howard C. Dittrich and is headquartered in Cleveland, OH. | Health Technology |
- Stock Market
- Insiders
- Arthur M. Brown
- Experience
